| 000 | 01730 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515050050.0 | ||
| 264 | 0 | _c20080124 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a0340-6199 | ||
| 024 | 7 |
_a10.1007/s00431-006-0327-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSong, Yun-Mi | |
| 245 | 0 | 0 |
_aFactors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. _h[electronic resource] |
| 260 |
_bEuropean journal of pediatrics _cAug 2007 |
||
| 300 |
_a813-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aApgar Score |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B _xblood |
| 650 | 0 | 4 |
_aHepatitis B Antibodies _xblood |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInfectious Disease Transmission, Vertical _xprevention & control |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Complications |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aSung, Joohon | |
| 700 | 1 | _aYang, Soonha | |
| 700 | 1 | _aChoe, Yon Ho | |
| 700 | 1 | _aChang, Yun Sil | |
| 700 | 1 | _aPark, Won Soon | |
| 773 | 0 |
_tEuropean journal of pediatrics _gvol. 166 _gno. 8 _gp. 813-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00431-006-0327-5 _zAvailable from publisher's website |
| 999 |
_c16691512 _d16691512 |
||